Translate
About
Kraneshares 2x Long Baba Daily Etf (NASDAQ:KBAB) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 2 2026
Immunovant Announces Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
Apr 2 2026
Roivant Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP) and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease (TED)
Apr 2 2026
Futu Announces Cash Dividend
Apr 2 2026
Priovant Expands Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris (LPP)
Apr 2 2026
Endeavour To Announce Its Q1 2026 Results On 30 April 2026